Mojo Max Fusion XXX, 500 mg, one capsule per blister card, 20 count box, Distributed by: Max Nutrition Inc. UPC 6 78945 36675 0
Published March 11, 2026 · Recall initiated: October 8, 2025
Summary
FDA records drug Class I recall D-0396-2026, published March 11, 2026 and initiated October 8, 2025. Recalling firm: Mohamed Hagar; Status: Ongoing; Reported quantity: 125 boxes; Lot: ALL LOTS, exp 12/31/2027. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule).
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Mohamed Hagar
- Distributor
- U.S. Nationwide
- Lot
- ALL LOTS, exp 12/31/2027
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe,March 11, 2026
- FDAMR. 7 SUPER 700000 capsules, 1 capsule blister card, Distributed by mR. 7March 11, 2026
- FDATirzepatide Inj, 10mg, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KSMarch 11, 2026
- FDAAmnesteem (Isotretinoin) Capsules, USP 40 mg, packaged in 3 x 10-Count Prescription Packs, Rx Only,March 11, 2026
- FDASemaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe,March 11, 2026
- FDAPremium Food Jordan Almonds, packed in 2.0 oz and 3.5 oz clear flexible plastic packaging.March 11, 2026
Questions about this recall
Was Mojo Max Fusion XXX, 500 mg, one capsule per blister card, 20 count box, Distributed by: Max Nutrition Inc. UPC 6 78945 36675 0 recalled?
Yes. FDA published recall D-0396-2026 on March 11, 2026. Reported hazard: Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule).
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail